✦ LIBER ✦

W1257 Infliximab for Severe Ulcerative Colitis: Short-Term and One Year Outcome of Three Dose Regimen. An Italian Multicentre Open-Label Study

✍ Scribed by Monterubbianesi, Rita; Daperno, Marco; Armuzzi, Alessandro; Biancone, Livia; Cappello, Maria; Lavagna, Alessandro; Annese, Vito; Orlando, Ambrogio; Viscido, Angelo; Riegler, Gabriele; Meucci, Gianmichele; Papi, Claudio; Sostegni, Raffaello; Guidi, Luisa; Marzo, Manuela; Petruzziello, Carmelina; Peralta, Sergio; Aratari, Annalisa; Prantera, Cosimo; Kohn, Anna

Book ID: 123542042
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 66 KB
Volume: 138
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(10)63148-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.80 INFLIXIMAB FOR SEVERE ULCERATIVE CO

P.80 INFLIXIMAB FOR SEVERE ULCERATIVE COLITIS: SHORT-TERM AND ONE YEAR OUTCOME OF THREE DOSE REGIMEN. AN ITALIAN MULTICENTRE OPEN-LABEL STUDY

✍ R. Monterubbianesi; M. Daperno; A. Armuzzi; L. Biancone; M. Cappello; A. Lavagna 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 59 KB

OC3.11.5 INFLIXIMAB FOR SEVERE ULCERATIV

OC3.11.5 INFLIXIMAB FOR SEVERE ULCERATIVE COLITIS: SHORT-TERM EFFICACY OF THREE-DOSE REGIMEN AND LONG-TERM OUTCOME. AN ITALIAN MULTICENTRIC OPEN-LABEL STUDY ON BEHALF OF THE IG-IBD

✍ A. Kohn; M. Daperno; A. Armuzzi; L. Biancone; M. Cappello; A. Lavagna; V. Annese 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Short and Long Term Outcome of Inflixima

Short and Long Term Outcome of Infliximab Scheduled Therapy for Acute, Severe Ulcerative Colitis. A Prospective, Open Label, Single-Centre, Two-Year Study

✍ Papamichael, Konstantinos ;Archavlis, Emmanuel J. ;Smyrnidis, Alexandros ;Agalos 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB